Shenzhen YHLO Biotech Co (SHSE:688575) EPS (Basic): ¥0.05 (TTM As of Mar. 2026)


SHSE:688575 Shenzhen YHLO Biotech Co Ltd SHSE:688575
64 GF Score
Price ¥8.77
GF Value ¥14.41
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shenzhen YHLO Biotech Co EPS (Basic)?

Shenzhen YHLO Biotech Co SHSE:688575 -1.57% 64 EPS (Basic) is ¥0.05 as of Mar. 2026. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.41 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shenzhen YHLO Biotech Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.05.

Shenzhen YHLO Biotech Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.05.

Shenzhen YHLO Biotech Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.11.

During the past 12 months, Shenzhen YHLO Biotech Co's average EPS without NRIGrowth Rate was -80.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -56.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Shenzhen YHLO Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 156.50% per year. The lowest was -56.30% per year. And the median was 34.40% per year.

Shenzhen YHLO Biotech Co  (SHSE:688575) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shenzhen YHLO Biotech Co EPS (Basic) Related Terms

Shenzhen YHLO Biotech Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Shenzhen YHLO Biotech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen YHLO Biotech Co EPS (Basic) Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only 0.38 1.79 0.63 0.53 0.04

Shenzhen YHLO Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.06 -0.07 0.03
SHSE:688575
64GF Score
Shenzhen YHLO Biotech Co Ltd SHSE:688575
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen YHLO Biotech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shenzhen YHLO Biotech Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(23.341-0)/583.515
=0.04

Shenzhen YHLO Biotech Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(17.951-0)/598.356
=0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥0.05 mean?
Shenzhen YHLO Biotech Co (SHSE:688575) has a EPS (Basic) of ¥0.05 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shenzhen YHLO Biotech Co and its competitors.
Is Shenzhen YHLO Biotech Co's EPS (Basic) too high?
Shenzhen YHLO Biotech Co's current EPS (Basic) is ¥0.05. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's EPS (Basic) compare to ABT and SYK?
Shenzhen YHLO Biotech Co's EPS (Basic) of ¥0.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shenzhen YHLO Biotech Co and its competitors. Shenzhen YHLO Biotech Co's current EPS (Basic) is ¥0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.41, compared to a current price of ¥8.77 — trading 39.1% below its estimated fair value. The current EPS (Basic) is ¥0.05. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current EPS (Basic) is ¥0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued. The current stock price of ¥8.77 is trading 39.1% below its estimated GF Value™ of ¥14.41. GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688575:

  • EPS (Basic): ¥0.05
  • GF Value™: ¥14.41 vs. price of ¥8.77 (39.1% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen YHLO Biotech Co Business Description

Address Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biotechnology Factory Area, Longgang District, Guangdong Province, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score

Get the complete analysis for SHSE:688575

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.77
Price
¥14.41
GF Value